Bhagiradha Chemicals & Industries delivered a remarkable financial turnaround in Q4 FY26, with the company reporting a consolidated net profit of ₹4.07 crore compared to a net loss of ₹0.88 crore in the corresponding quarter of the previous year. According to reports from Business Standard, the agrochemical manufacturer's revenue from operations jumped 28.93% year-on-year to ₹158.10 crore in the quarter ended March 31, 2026. The company's profit before tax (PBT) stood at ₹4.81 crore in Q4 FY26, registering a substantial growth of 114.73% from ₹2.24 crore reported in Q4 FY25.
For the complete financial year FY26, Bhagiradha Chemicals demonstrated consistent growth across key financial parameters. As reported by Business Standard, the company posted a 31.09% increase in consolidated net profit to ₹18.17 crore for the full year, while revenue from operations rose 21.67% to ₹535.94 crore compared with FY25. The company's net cash used in operating activities stood at ₹12.01 crore in FY26, representing a significant improvement from the negative net cash from operating activities of ₹52.80 crore recorded in FY25.
The company's board has recommended a final dividend of ₹0.15 per equity share of face value Re 1 each (15%) for the financial year ended March 31, 2026, subject to shareholders' approval at the upcoming 33rd Annual General Meeting. According to Business Standard, Thursday, July 23, 2026, has been fixed as the record date for determining shareholder eligibility to receive the final dividend. If approved by shareholders, the dividend will be paid within the prescribed timeline under applicable law, subject to deduction of applicable taxes.
Following the strong quarterly results announcement, Bhagiradha Chemicals & Industries shares gained 1.04% to ₹251.60 in the trading session. As reported by Business Standard, the agrochemical company is involved in the manufacturing of insecticides, fungicides, and herbicides in India. The positive market response reflects investor confidence in the company's operational turnaround and consistent growth trajectory across both quarterly and annual financial metrics.
